Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.

Gabbi, Chiara; Renieri, Alessandra; Strandvik, Birgitta

Gabbi, Chiara; Renieri, Alessandra; Strandvik, Birgitta.

Afiliación

Gabbi C; Department of Biosciences and Nutrition, Karolinska Institutet, Neo, SE-141 83, Huddinge, Sweden. Electronic address: chiaragabbi@virgilio.it.
Renieri A; Medical Genetics, University of Siena, Siena, Italy; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Italy.
Strandvik B; Department of Biosciences and Nutrition, Karolinska Institutet, Neo, SE-141 83, Huddinge, Sweden.

J Infect ; 85(3): 318-321, 2022 09.

Article en En | MEDLINE | ID: mdl-35700866

Asunto(s)

COVID-19; Regulador de Conductancia de Transmembrana de Fibrosis Quística; Fibrosis Quística; Heterocigoto; COVID-19/epidemiología; COVID-19/mortalidad; Fibrosis Quística/complicaciones; Fibrosis Quística/epidemiología; Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética; Genética de Población; Humanos; Mutación

Palabras clave

CF carriers; CFTR; COVID-19; Cystic fibrosis; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulador de Conductancia de Transmembrana de Fibrosis Quística / Fibrosis Quística / COVID-19 / Heterocigoto Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Infect Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google